Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.34
-0.05 (-3.60%)
At close: Sep 29, 2025, 3:59 PM
1.36
1.49%
After-hours: Sep 29, 2025, 07:42 PM EDT
Telomir Pharmaceuticals Common Stock Revenue
Telomir Pharmaceuticals Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Telomir Pharmaceuticals Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
1
Market Cap
43.95M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |